114 filings
8-K
BXRXQ
Baudax Bio, Inc.
28 Feb 24
Bankruptcy or Receivership
6:15am
8-K
BXRXQ
Baudax Bio, Inc.
12 Dec 23
Other Events
9:52pm
8-K
BXRXQ
Baudax Bio, Inc.
15 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
BXRXQ
Baudax Bio, Inc.
25 Oct 23
Changes in Registrant's Certifying Accountant
7:57am
8-K
BXRXQ
Baudax Bio, Inc.
13 Oct 23
Submission of Matters to a Vote of Security Holders
7:00am
8-K
c1itkagcy9 1mgfq02r
6 Oct 23
Departure of Directors or Certain Officers
8:00am
8-K
yfe t1ewssa
29 Sep 23
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
7:01am
8-K/A
xrw8xshb r78hbgx
7 Sep 23
Financial Statements and Exhibits
4:06pm
8-K
9tgp 4x5h
5 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
4d09qyh
25 Aug 23
Entry into a Material Definitive Agreement
8:03am
8-K
ppqcf6rn
24 Aug 23
Material Modifications to Rights of Security Holders
5:07pm
8-K
kdsq00h01
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
8-K
oe9fx 1up4cj
16 Aug 23
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
8:11am
8-K/A
qczon cab70uq
9 Aug 23
Other Events
5:27pm
8-K/A
hzj a6go81dhwzf4h6t
31 Jul 23
Entry into a Material Definitive Agreement
4:54pm
8-K
59ds1n
25 Jul 23
Other Events
8:01am
8-K
kq9j562attsl
17 Jul 23
Other Events
7:00am
8-K
u1p5oacf0 sn
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
8-K
4xdetyd58xz3i
28 Jun 23
Other Events
4:31pm
8-K
57rfol
27 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm